A New Drug Pair Killed Glioblastoma Cells in the Lab
Original title: Potent Anti-Glioblastoma Effects of Next-Generation MNK Inhibitors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in lab dishes, not in people.
The short version
In lab dishes, two drugs used together stopped glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells from growing and made them die.
What was studied. Scientists built a new drug called NUCC-201893. It blocks a protein called MNK that helps tumors grow. They tested it on glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells in the lab, including cells taken from patients and grown as tiny clusters.
What they found. The new drug hit its target more precisely and worked better than the earlier drug, NU808. It slowed the cells down. They grew less, moved less, and spread less. The team then tried it with a second kind of drug that blocks DNMT. Together the two drugs shrank the cell clusters more and pushed more cancer cells to die.
What this means, and what it doesn't
What it could mean: This gives researchers a new pair of drugs worth studying for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. It is an early idea, not a treatment. No doctor can offer this today.
What it doesn't mean: This does not mean a new treatment is close. All of this was done on cells in lab dishes. It was not tested in people, and it was not even tested in animals. It is not a cure, and it is not a promise of one. Many things that kill cancer cells in a dish never end up helping patients. Years of further testing would have to come first.
Source: PubMed, June 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.